How Vildagliptin Improves Time in Range in T2DM patients ft-Prof. Dr Aravinda Jagadeesha Dr. Nandita Mohan10 Jan 2023 11:00 AM IST The increased alpha and beta cell sensitivity to glucose by DPP4 inhibitors modulate not only chronic hyperglycemia but also daily glucose...
Evaluating DPP4 inhibition and Bioequivalence of Vildagliptin 100mg SR ft Prof. Dr Aravinda Jagadeesha Dr. Nandita Mohan2 Jan 2023 10:45 AM IST Vildagliptin, a potent dipeptidyl peptidase IV inhibitor (DPP-4i), is usually administered twice daily to provide >90% inhibition of DPP-4 over...
Safety and Efficacy of Vildagliptin 100mg SR- Ft. Prof. Dr Aravinda Jagadeesha Dr. Nandita Mohan15 Dec 2022 11:17 AM IST Among the gliptins, vildagliptin is the only therapy requiring twice-daily dosing and thus adversely impacts patient adherence. To reduce dosing...
Overviewing Cardiac Safety Profile of Vildagliptin 100mg SR -ft-Prof. Dr Aravinda Jagadeesha Dr. Nandita Mohan5 Dec 2022 12:00 PM IST Vildagliptin has established itself over the years by controlling the blood sugar levels in patients with type 2 diabetes mellitus. It is used along...
Hepatic Safety Profile of Vildagliptin 100 mg SR - Ft. Prof. Dr Aravinda Jagadeesha Dr. Nandita Mohan26 Nov 2022 12:33 PM IST Vildagliptin has established its efficacy over the years by displaying significant HbA1c lowering accompanied by body weight-neutral and...
